ISAR-REACT 4 Trial Backs Bivalirudin for NSTEMI
November 13, 2011|Internal Medicine News
Author and Disclosure Information
FROM THE ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION
The full results of the trial were simultaneously published online in the New England Journal of Medicine (2011 Nov. 13 [doi:10.1056/NEJMoa1109596]).
Nycomed Pharma sponsored the trial. Dr. Kastrati reported speaker fees or honoraria from Abbott, AstraZeneca, Bristol-Myers Squibb, Cordis, Daichii Sankyo/Lilly, and Medtronic. Dr. Bhatt reported research grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi-Aventis, and The Medicines Company. Dr. Harrington is an adviser and/or consultant to AstraZeneca, Johnson & Johnson, Merck, Novartis, Pfizer, Portola, Regado, and Sanofi-Aventis.
